HOME Press Releases Pen Needles Market worth 2.81 Billion USD by 2021



Pen Needles Market worth 2.81 Billion USD by 2021


The report "Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021", This report studies the pen needles market for the forecast period of 2016 to 2021. This market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2%.

                 Request Sample                 Request Sample

Browse 102 market data Tables and 53 Figures spread through 185 Pages and in-depth TOC on "Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021"
http://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html
Early buyers will receive 10% customization on reports.

A number of factors such as the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and needle anxiety; growing diabetic population; and conferences, meetings, and congresses to create pen needle awareness are expected to drive the growth of the pen needles market during the forecast period.

In this report, the pen needles market is segmented on the basis of type, needle length, therapy, mode of purchase, and region. Based on type, the pen needles market is categorized into standard pen needles and safety pen needles. The standard pen needles segment is expected to account for the largest share of the pen needles market in 2016. However, the safety pen needles segment is projected to grow at a higher CAGR during the forecast period.

Based on needle length, the pen needles market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm needle length segment is expected to account for the largest share of the market in 2016. However, the 4mm needle length segment is expected to grow at the highest CAGR during the forecast period.

On the basis of therapy, the pen needles market is segmented insulin therapy, growth hormone therapy, and Glucagon-like Peptide-1 (GLP-1) therapy. The insulin therapy segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.

Based on mode of purchase, the pen needles market is segmented into retail and non-retail purchase. The retail purchase segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR during the forecast period.

Geographically, the global pen needles market is divided into North America, Europe, Asia, and the Rest of the World (Latin America, Pacific countries, the Middle East, and Africa). Europe is expected to account for the largest share of the pen needles market in 2016, followed by North America, Asia, and the Rest of the World. The Asian market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering pen needle products

Prominent players in the global pen needles market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports